EGR1 and cardiac hypertrophy: In this regard, recent studies indicate that the naturally occurring agent astragaloside IV inhibits cardiac hypertrophy through ERK and PKCβII/Egr-1 activation in rodents born from mothers with intrauterine hypoxia (84).